BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7563659)

  • 1. [Features and therapy of the patients with chronic hepatitis C resistant to IFN therapy].
    Imazeki F; Yokosuka O; Omata M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):1017-21. PubMed ID: 7563659
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of chronic hepatitis C: still many problems pending].
    Bruguera M
    Gastroenterol Hepatol; 1997 Jan; 20(1):31-42. PubMed ID: 9072195
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of ursodeoxycholic acid in treatment of chronic hepatitis C].
    Warunek W; Zejc-Bajsarowicz M; Librant-Suska M
    Folia Med Cracov; 1996; 37(1-2):97-100. PubMed ID: 9312530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The therapy of hepatitis C in the failure of interferon].
    Hermann R; Maier KP
    Dtsch Med Wochenschr; 1997 Aug; 122(34-35):1049-54. PubMed ID: 9312461
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapy.
    El-Zayadi AR; Attia M; Badran HM; El-Tawil A; Zalata K; Barakat E; Selim O; El-Nakeeb A; Saied A
    Liver Int; 2005 Aug; 25(4):746-51. PubMed ID: 15998425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alternative treatment to interferon therapy in chronic viral hepatitis].
    Salmerón Escobar FJ
    Gastroenterol Hepatol; 1995 Oct; 18(8):430-6. PubMed ID: 7584785
    [No Abstract]   [Full Text] [Related]  

  • 7. Introduction: combination antiviral therapy in chronic hepatitis C.
    Sherlock S
    J Hepatol; 1995; 23 Suppl 2():1-2. PubMed ID: 8720285
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiviral therapy of hepatitis C].
    Erhardt A; Petry W; Ebel M; Jablonowski H; Heintges T; Häussinger D
    Z Gastroenterol; 2000 Mar; 38(3):259-69. PubMed ID: 10768250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant interferon-alpha and ursodeoxycholic acid versus interferon-alpha alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up.
    Angelico M; Gandin C; Pescarmona E; Rapicetta M; Del Vecchio C; Bini A; Spada E; Baroni CD; Capocaccia L
    Am J Gastroenterol; 1995 Feb; 90(2):263-9. PubMed ID: 7847298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid for chronic hepatitis C patients.
    Puoti C; Magrini A; Annovazzi G; Pannullo A; Filippi T
    Hepatology; 1995 Sep; 22(3):1002. PubMed ID: 7657266
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antiviral treatment of chronic hepatitis].
    Müller R
    Internist (Berl); 1984 Dec; 25(12):728-34. PubMed ID: 6083989
    [No Abstract]   [Full Text] [Related]  

  • 12. [Criteria of IFN treatment for chronic hepatitis C].
    Yano M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):986-90. PubMed ID: 7563915
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluating the efficacy of interferon therapy on hepatitis C patients].
    Shiraha H; Iwasaki Y; Shiratori Y
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):489-92. PubMed ID: 15359847
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antiviral preparations in the therapy of chronic viral hepatitis].
    Geller LI
    Ter Arkh; 1990; 62(11):15-9. PubMed ID: 1710074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral agents in the treatment of chronic viral hepatitis.
    Perrillo RP
    Prog Liver Dis; 1992; 10():283-309. PubMed ID: 1284255
    [No Abstract]   [Full Text] [Related]  

  • 17. The interferon sensitivity determining region: all hepatitis C virus isolates are not the same.
    Herion D; Hoofnagle JH
    Hepatology; 1997 Mar; 25(3):769-71. PubMed ID: 9049233
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of action of interferon and ribavirin in treatment of hepatitis C.
    Feld JJ; Hoofnagle JH
    Nature; 2005 Aug; 436(7053):967-72. PubMed ID: 16107837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes and costs of care in hepatitis C: combination therapy scores again.
    Koff RS
    Am J Gastroenterol; 2000 Jun; 95(6):1392-3. PubMed ID: 10894568
    [No Abstract]   [Full Text] [Related]  

  • 20. Interferon versus interferon and UDCA combined therapy in chronic hepatitis C.
    Mazur W; Machniak M; Mazurek U; Jurzak M; Wilczok T; Gonciarz Z
    Med Sci Monit; 2001 May; 7 Suppl 1():157-64. PubMed ID: 12211712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.